Vaccinex, Inc. Accounts Payable
Vaccinex, Inc. (VCNX) had Accounts Payable of $3.96 million as of 2024-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2025-04-15
- 2024-12-31: Accounts Payable, Current $3.96M.
- 2024-09-30: Accounts Payable, Current $4.87M.
- 2024-06-30: Accounts Payable, Current $3.24M.
- 2024-03-31: Accounts Payable, Current $2.33M.
| Period end | Accounts Payable, Current |
|---|---|
| 2024-12-31 | $3.96M 10-K · filed 2025-04-15 |
| 2024-09-30 | $4.87M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $3.24M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $2.33M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $2.04M 10-K · filed 2025-04-15 |
| 2023-09-30 | $4.22M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $1.61M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $1.09M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $1.52M 10-K/A · filed 2024-04-25 |
| 2022-09-30 | $494.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $265.00K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $589.00K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $1.06M 10-K · filed 2023-03-31 |
| 2021-09-30 | $957.00K 10-Q · filed 2021-11-08 |
| 2021-06-30 | $1.72M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $3.25M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $3.17M 10-K · filed 2022-03-31 |
| 2020-09-30 | $2.94M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $5.37M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $3.30M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $3.21M 10-K · filed 2021-03-31 |
| 2019-09-30 | $2.34M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $5.45M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $2.44M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $2.32M 10-K · filed 2020-03-09 |
| 2018-09-30 | $2.28M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $3.61M 10-Q · filed 2018-08-14 |
| 2017-12-31 | $1.91M 10-K · filed 2019-03-13 |